Avestria Ventures

CurioInvest is a financial technology company specializing in the tokenization of real-world assets, with a primary focus on collectible and rare exclusive cars. By leveraging blockchain technology, CurioInvest aims to make investments in this lucrative market accessible to a broader audience, eliminating high capital requirements and costly intermediaries. The company recognizes that collectible cars have significantly outperformed traditional investment indices since 2008 and seeks to pioneer the adoption of distributed ledger technologies within the automotive sector. Through its innovative platform, CurioInvest enables investors to directly participate in the market for high-value collectibles, simplifying the investment process and fostering a new era of asset ownership.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in women's pelvic health, particularly addressing the medical and social challenges associated with urinary and fecal incontinence. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic designed for at-home treatment of urinary incontinence and chronic fecal incontinence. The system employs patented technology that allows for non-invasive, drug-free treatment by providing real-time visualization of pelvic floor movements while tracking usage and progress. This approach empowers women to strengthen their pelvic floor and alleviate symptoms related to various types of incontinence, including stress, mixed, and urgency incontinence, ultimately improving their quality of life.

May Health is a healthcare company focused on addressing infertility related to Polycystic Ovary Syndrome (PCOS). The company has developed an innovative, minimally invasive procedure aimed at restoring ovulation in women with PCOS. This one-time treatment is performed transvaginally under ultrasound guidance, allowing for its execution in a clinical setting without the need for general anesthesia. May Health's approach seeks to provide patients with a more natural pregnancy experience by assisting the body to ovulate as it would naturally, thereby offering a less medicalized alternative to traditional fertility treatments.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Avation Medical, Inc. is a company focused on developing a non-invasive closed-loop neuromodulation system aimed at treating overactive bladder in a home setting. Incorporated in 2016 and based in Columbus, Ohio, Avation Medical is at the forefront of innovation in wearable nerve stimulation systems. The company emphasizes empowering patients to manage their therapies, facilitating a more personalized approach to care. By leveraging advanced technologies, Avation Medical seeks to transform the neuromodulation market, enhancing the quality of care for individuals with chronic conditions through patient-centric solutions.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in women's pelvic health, particularly addressing the medical and social challenges associated with urinary and fecal incontinence. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic designed for at-home treatment of urinary incontinence and chronic fecal incontinence. The system employs patented technology that allows for non-invasive, drug-free treatment by providing real-time visualization of pelvic floor movements while tracking usage and progress. This approach empowers women to strengthen their pelvic floor and alleviate symptoms related to various types of incontinence, including stress, mixed, and urgency incontinence, ultimately improving their quality of life.

AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

Rhinostics is a company focused on enhancing laboratory workflows through innovative sample collection solutions. It develops specialized sample collection kits designed for various tests, including COVID-19, aimed at increasing efficiency, accuracy, and safety in laboratory environments. By introducing new materials and collection methods, Rhinostics improves sample collection performance while significantly reducing costs and time associated with traditional processes. The company’s products facilitate rapid accessioning and automation, minimizing the need for human intervention and enhancing throughput. As a result, laboratories benefit from lowered labor costs, improved safety protocols, and reduced rates of sample contamination and errors.

AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

Fogarty Innovation is a nonprofit organization based in Mountain View, California, focused on advancing medical innovation to enhance human health. Founded in 2007, the organization supports promising innovators and researchers by transforming their creative ideas into practical solutions that improve patient care. It operates as an incubator, providing essential funding, mentorship, and research tools to facilitate the development of medical concepts from inception to application. Fogarty Innovation offers two key programs: one aimed at fostering innovation for startups and another dedicated to educating the next generation of inventors. Through these initiatives, Fogarty Innovation coordinates access to vital intellectual, physical, and financial resources to drive medical advancements.

Raydiant Oximetry, Inc. is a medical device company established in 2015 and headquartered in Mountain View, California. The company specializes in the development of a low-cost, non-invasive device that monitors fetal oxygen levels during labor, with the aim of improving health outcomes for mothers and their babies. By providing real-time data on fetal oxygenation, Raydiant Oximetry's technology seeks to enhance patient care, reduce the occurrence of unnecessary cesarean sections, and lower healthcare costs associated with childbirth. The company's innovations are designed to address potential birth injuries and minimize over-intervention in the delivery process, ultimately striving to improve the overall experience and safety of childbirth.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Rhinostics is a company focused on enhancing laboratory workflows through innovative sample collection solutions. It develops specialized sample collection kits designed for various tests, including COVID-19, aimed at increasing efficiency, accuracy, and safety in laboratory environments. By introducing new materials and collection methods, Rhinostics improves sample collection performance while significantly reducing costs and time associated with traditional processes. The company’s products facilitate rapid accessioning and automation, minimizing the need for human intervention and enhancing throughput. As a result, laboratories benefit from lowered labor costs, improved safety protocols, and reduced rates of sample contamination and errors.

Alydia Health, Inc. is a medical device company focused on addressing postpartum hemorrhage (PPH), a leading cause of maternal mortality. Founded in 2010 and based in Menlo Park, California, the company designs and manufactures the Jada System, a device that helps control excessive bleeding after childbirth by promoting normal uterine contractions. This innovative approach provides an effective solution without the need for pharmaceuticals, hysterectomy, or other surgical interventions, thereby improving treatment options for women experiencing PPH. Alydia Health aims to significantly enhance the management of postpartum hemorrhage, ultimately improving maternal health outcomes worldwide.

Knowledge to Practice is an education technology company based in Bethesda, United States, founded in 2014. The company focuses on enhancing postgraduate medical education by providing self-directed learning solutions and self-assessment tools that help identify knowledge gaps among clinicians. Its platform employs advanced learning techniques and digital technology to deliver personalized curricula aimed at improving clinical judgment, critical thinking, and patient care. By enabling physicians to improve their performance and reduce variations in care, Knowledge to Practice fosters a more effective and efficient healthcare environment. The company's offerings include repeatable content modules, facilitating continuous learning and professional development for healthcare professionals.

Raydiant Oximetry, Inc. is a medical device company established in 2015 and headquartered in Mountain View, California. The company specializes in the development of a low-cost, non-invasive device that monitors fetal oxygen levels during labor, with the aim of improving health outcomes for mothers and their babies. By providing real-time data on fetal oxygenation, Raydiant Oximetry's technology seeks to enhance patient care, reduce the occurrence of unnecessary cesarean sections, and lower healthcare costs associated with childbirth. The company's innovations are designed to address potential birth injuries and minimize over-intervention in the delivery process, ultimately striving to improve the overall experience and safety of childbirth.